Hot Flushes: Clinical Trials

3 trials for Hot Flushes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Hot Flushes: new trials by email Literature Review of Hot Flushes trials Research Report on Hot Flushes

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
Estetrol, Placebo - Hot Flushes
Phase 2CompletedDonesta Bioscience2602016-05-012024-11-18
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Bupivicaine, Saline - Hot Flushes, Hot Flashes
Phase 2CompletedNorthwestern University372015-07-012023-06-05
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
soy protein, isoflavones, Tamoxifen - Breast Cancer, Hot Flashes
Phase 2CompletedAlliance for Clinical Trials in Oncology1122002-03-012016-07-13

Narrower conditions

Hot Flashes (3)  ·  Breast Neoplasms (2)  ·  Breast Carcinoma In Situ (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Bupivacaine (1)  ·  Estetrol (1)  ·  Isoflavones (1)  ·  Sodium Chloride (1)  ·  Soybean Proteins (1)  ·  Tamoxifen (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  Donesta Bioscience (1)  ·  Northwestern University (1)

Countries

United States (2)  ·  Belgium (1)

Top investigators

David R. Walega, MD, MSCI (1)  ·  Donesta Bioscience (1)  ·  Gini F. Fleming, MD (1)

Results publications

PMID 33110036, PMID 36809193

NIH funding

2015 (1), U10CA076001 (1)